Popular on s4story
- Bald Guy Greetings Launches Bold New Postcard Line Celebrating Over-the Top (and Often Delusional) Confidence
- DMV Native And Eight-Time Emmy Winner Justin W. Brown Directs A Moving Tribute To A Community's Legacy
- Two exciting new fantasy & adventure books are published
- Charming Ogawamachi Town, in Saitama Prefecture, Japan, Announces Festivals for 2025
- Jumpstart Summer Adventures at the Y
- MAJOR New release of Krypto500 (ELF-HF) Sigint - COMINT software
- Transform Your Home with Expert Kitchen Remodeling Near Bloomington, MN
- Large Strategic Investment from Global Medical Device Manufacturer to Support Clinics Treating Suicidal Depression and PTSD: NRx: (Stock Symbol: NRXP)
- Homeowners Turn to Smart Kitchen Remodeling Companies in Fort Lauderdale
- Robotphoenix to Jointly Exhibit with DERI SRL at IPACK-IMA 2025 in Milan
Similar on s4story
- Barcelona-based Neurosurgical Specialist Awarded Designation of International Center of Excellence for Ehlers Danlos Syndrome
- Pregis Expands Multi-Layer Technology for High-Performance Barrier Films at Anderson Facility
- New Professional Association to Study Principles of Hospitality Applied to the Delivery of Healthcare
- Clinical Endpoints Successfully Met in Study for Groundbreaking 12-Lead ECG Synthesis Technology Allowing Software Application to FDA: HeartBeam, Inc
- Boston Industrial Solutions, Inc. Unveils Natron® 504N UV LED Inks Designed for EPSON Printheads
- Kavelle Christie: Trump's First 100 Days Mark Alarming Breakdown in Healthcare, Public Health, and Freedoms
- New WHO Mental Health Guidelines Condemn Coercive Psychiatry
- Keenan's Caring Konnections, LLC
- OpsVeda Announces Launch of TariffSight, the World's First Comprehensive Platform to Address Tariff-Driven Challenges
- New Build-to-Suit VA Medical Office Facility Coming to Highland Heights, KY
Successful Completion of Australia's Therapeutic Goods Administration (TGA) Audit
S For Story/10628251
SAN JOSE, Calif. - s4story -- CPC announces the completion of a rigorous four-day audit conducted by Australia's Therapeutic Goods Administration (TGA), the country's government authority responsible for evaluating, assessing, and monitoring approved products defined as therapeutic goods. As a globally recognized peptide and oligonucleotide manufacturer, with our facilities built and operated to WHO GMP, FDA 21 CFR 210/211, and ICH Q7 standards, this audit marks a significant milestone in the company's ongoing commitment to ensuring the highest standards of quality and compliance. Our manufacturing facility in Hangzhou, China, was awarded an A2 compliance rating. This inspection certifies Good Manufacturing Practice (GMP) compliance of three commercial peptide active pharmaceutical ingredients (APIs). This achievement underscores our commitment to maintaining the highest quality standards in peptide production and ensures that our products meet stringent international regulatory requirements.
More on S For Story
About CPC Scientific.
Founded in 2001, we are the third largest peptide-focused contract research, development, and manufacturing organization ("CRDMO") worldwide in the of terms of sales revenue in 2023, according to Frost & Sullivan. We are also considered one of the most comprehensive peptide-focused CRDMO globally (Frost & Sullivan), offering complete life-cycle support from early-discovery, pre-clinical research and clinical development to commercial production.
Our operations in China are conducted in our facility located at No. 69, Street 12 of Qiantang District, Hangzhou ("Qiantang Site"), situated on our approximately 26,000 square meter CGMP campus. The constructed manufacturing CGMP facility has a gross floor area ("GFA") of over 15,000 square meters. Our production facilities adhere rigorously to CGMP as mandated by major regulatory authorities globally, including the U.S. Food and Drug Administration ("FDA"), National Medical Products Administration ("NMPA"), European Medicines Agency ("EMA"), Therapeutic Goods Administration ("TGA"), and Korean Ministry of Food and Drug Safety ("MFDA"). We have successfully passed four FDA audits without receiving FDA-483 observations (FDA notice highlighting regulatory violations found during an inspection) as of the Latest Practicable Date ("LPD"). In addition, our facility holds ISO9001 and ISO13485 certifications for quality management systems.
More on S For Story
In addition to the Qiantang Site, we also have GMP production facilities under construction in the United States and Hangzhou, China, with a total GFA of 4,000 and 26,700 square meters, respectively. All our production facilities are equipped with advanced equipment and instrumentation supplied by top-tier equipment suppliers such as Agilent, Waters, Thermo Fisher, Cytiva, Jianbang, and Hanbang.
website
More on S For Story
- Seecoin Expands Beyond Gaming: A Web3 (r)evolution for All Content Creators
- Barcelona-based Neurosurgical Specialist Awarded Designation of International Center of Excellence for Ehlers Danlos Syndrome
- Author Makeda Releases New Book Built Not Bought—A Powerful Guide to Creating an Intentional Life
- Pregis Expands Multi-Layer Technology for High-Performance Barrier Films at Anderson Facility
- New Professional Association to Study Principles of Hospitality Applied to the Delivery of Healthcare
About CPC Scientific.
Founded in 2001, we are the third largest peptide-focused contract research, development, and manufacturing organization ("CRDMO") worldwide in the of terms of sales revenue in 2023, according to Frost & Sullivan. We are also considered one of the most comprehensive peptide-focused CRDMO globally (Frost & Sullivan), offering complete life-cycle support from early-discovery, pre-clinical research and clinical development to commercial production.
Our operations in China are conducted in our facility located at No. 69, Street 12 of Qiantang District, Hangzhou ("Qiantang Site"), situated on our approximately 26,000 square meter CGMP campus. The constructed manufacturing CGMP facility has a gross floor area ("GFA") of over 15,000 square meters. Our production facilities adhere rigorously to CGMP as mandated by major regulatory authorities globally, including the U.S. Food and Drug Administration ("FDA"), National Medical Products Administration ("NMPA"), European Medicines Agency ("EMA"), Therapeutic Goods Administration ("TGA"), and Korean Ministry of Food and Drug Safety ("MFDA"). We have successfully passed four FDA audits without receiving FDA-483 observations (FDA notice highlighting regulatory violations found during an inspection) as of the Latest Practicable Date ("LPD"). In addition, our facility holds ISO9001 and ISO13485 certifications for quality management systems.
More on S For Story
- Clinical Endpoints Successfully Met in Study for Groundbreaking 12-Lead ECG Synthesis Technology Allowing Software Application to FDA: HeartBeam, Inc
- Bone Flute: A Woman Speaks Launches
- Boston Industrial Solutions, Inc. Unveils Natron® 504N UV LED Inks Designed for EPSON Printheads
- Kavelle Christie: Trump's First 100 Days Mark Alarming Breakdown in Healthcare, Public Health, and Freedoms
- La'Nardo Myrick Sr. Honors Women's Strength with New Poetry Collection
In addition to the Qiantang Site, we also have GMP production facilities under construction in the United States and Hangzhou, China, with a total GFA of 4,000 and 26,700 square meters, respectively. All our production facilities are equipped with advanced equipment and instrumentation supplied by top-tier equipment suppliers such as Agilent, Waters, Thermo Fisher, Cytiva, Jianbang, and Hanbang.
website
Source: CPC Scientific Inc.
0 Comments
Latest on S For Story
- "Mindful Moments" Helps Families Cultivate Calm in Chaotic World Through Child-Friendly Mindfulness Practices
- Chapter 3: The Molestation from A Letter to Pawtone
- Lyricalmar Set To Release Powerful New Ep "MARCHIVES" May 16
- Charleston, SC - ACSEC offers Rain Barrels Through Annual Program
- Greek Government Issues Landmark Ministerial Order Addressing Citizenship of Greek-born adoptees
- Former Orange County Commissioner Homer Hartage Announces Heartwarming New Children's Picture Book
- Baltimore Author Crafts Space Opera Where Human Questions Outshine Galactic Scale
- Stout Surpasses 60,000 Acres and 3 Billion Plants Scanned
- OpsVeda Announces Launch of TariffSight, the World's First Comprehensive Platform to Address Tariff-Driven Challenges
- Two exciting new fantasy & adventure books are published
- MAJOR New release of Krypto500 (ELF-HF) Sigint - COMINT software
- "The Eyes Have It" a Short Story by Philip K. Dick Now Available on Audiobook
- New Build-to-Suit VA Medical Office Facility Coming to Highland Heights, KY
- Fairfield Inn by Marriott Scottsdale Old Town Opens
- Make Cursive Fun Again with the New Writing Scholars Activity Book
- Bilingual Learning Made Fun: Tagalog-English Body Parts Book for Kids
- "The Memory Box, Charlotte's Big Surprise" Now Available at Barnes & Noble"
- Pelican Reef Group Announces Grand Opening of New High Point Showroom – IHFC Building H-621 & Event April 27th, 2025
- NaturismRE Launches the 11 Levels of Naturism: A Groundbreaking Framework Guiding the Global Naturist Journey
- K2 Integrity and Sonata One Partner to Accelerate Capital Raising, Reduce Risk, and Deliver Scalable Advisory Services for Private Fund Managers